| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.56 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |